Comments
Loading...

Jasper Therapeutics

JSPRNASDAQ
Logo brought to you by Benzinga Data
$22.74
-0.23-1.00%
At Close: -
$22.74
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Outperform
Highest Price Target1
$90.00
Lowest Price Target1
$4.00
Consensus Price Target1
$47.57

Jasper Therapeutics (NASDAQ:JSPR) Stock, Analyst Ratings, Price Targets, Forecasts

Jasper Therapeutics Inc has a consensus price target of $47.57 based on the ratings of 16 analysts. The high is $90 issued by BTIG on July 8, 2024. The low is $4 issued by Credit Suisse on August 14, 2023. The 3 most-recent analyst ratings were released by JMP Securities, Evercore ISI Group, and RBC Capital on September 9, 2024, August 26, 2024, and August 14, 2024, respectively. With an average price target of $67.67 between JMP Securities, Evercore ISI Group, and RBC Capital, there's an implied 197.57% upside for Jasper Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
May
1
Jun
0
0
0
0
Jul
2
Aug
1
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

JMP Securities
Evercore ISI Group
RBC Capital
HC Wainwright & Co.
BTIG

1calculated from analyst ratings

Analyst Ratings for Jasper Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Jasper Therapeutics (JSPR) stock?

A

The latest price target for Jasper Therapeutics (NASDAQ:JSPR) was reported by Cantor Fitzgerald on September 9, 2024. The analyst firm set a price target for $0.00 expecting JSPR to fall to within 12 months (a possible -100.00% downside). 17 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Jasper Therapeutics (JSPR)?

A

The latest analyst rating for Jasper Therapeutics (NASDAQ:JSPR) was provided by Cantor Fitzgerald, and Jasper Therapeutics reiterated their overweight rating.

Q

When was the last upgrade for Jasper Therapeutics (JSPR)?

A

There is no last upgrade for Jasper Therapeutics

Q

When was the last downgrade for Jasper Therapeutics (JSPR)?

A

There is no last downgrade for Jasper Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Jasper Therapeutics (JSPR)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Jasper Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Jasper Therapeutics was filed on September 9, 2024 so you should expect the next rating to be made available sometime around September 9, 2025.

Q

Is the Analyst Rating Jasper Therapeutics (JSPR) correct?

A

While ratings are subjective and will change, the latest Jasper Therapeutics (JSPR) rating was a reiterated with a price target of $0.00 to $0.00. The current price Jasper Therapeutics (JSPR) is trading at is $22.74, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch